Diffuse pulmonary lymphangiomatosis treated with bevacizumab

Diffuse pulmonary lymphangiomatosis (DPL) is a rare disease caused by uncontrolled lymphatic vessel proliferation resulting in respiratory dysfunction. Lymphatic vessel growth is influenced by vascular endothelial growth factor (VEGF). It has been shown that bevacizumab, a monoclonal antibody to VEG...

Fuld beskrivelse

Na minha lista:
Bibliografiske detaljer
Udgivet i:Respirol Case Rep
Main Authors: Onyeforo, Ernest, Barnett, Adrian, Zagami, Debbie, Deller, David, Feather, Iain
Format: Artigo
Sprog:Inglês
Udgivet: John Wiley & Sons, Ltd 2018
Fag:
Case Reports
Online adgang:https://ncbi.nlm.nih.gov/pmc/articles/PMC6260917/
https://ncbi.nlm.nih.gov/pubmed/30510764
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/rcr2.384
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!

Lignende værker